To validate our findings, we interrogated the LINCS dataset for the most frequently upregulated and downregulated genes in OC and breast cancer (genomically related cancers driven by copy-number aberration and hormone regulation) cell lines treated with PI3K–AKT inhibitors (n = 34; Methods). The gene discussed is PIK3CA; the disease is breast carcinoma.